Effectiveness, reliability, and validity of new Japanese diagnostic criteria for obstetrical disseminated intravascular coagulation

Since July 2022, obstetrical disseminated intravascular coagulation (DIC) in Japan has been diagnosed based on the new criteria (tentative version), which assesses the main underlying disease, fibrinogen level, and fibrin/fibrinogen degradation products or D-dimer level. In June 2024, the tentative...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2024-07, Vol.14 (1), p.17677-11, Article 17677
Main Authors: Morikawa, Mamoru, Takeda, Yoshiharu, Matsunaga, Shigetaka, Makino, Shintaro, Eto, Eriko, Serizawa, Mariko, Nii, Masafumi, Takeda, Jun, Masuyama, Hisashi, Itakura, Atsuo
Format: Article
Language:English
Subjects:
692/53/2421
692/700/139/1735
Adult
Blood transfusion
Cesarean Section
Coagulation
Criteria
Degradation products
Disseminated intravascular coagulation
Disseminated Intravascular Coagulation - blood
Disseminated Intravascular Coagulation - diagnosis
East Asian People
Female
Fibrin
Fibrin Fibrinogen Degradation Products - analysis
Fibrinogen
Fibrinogen - analysis
Fibrinogen - metabolism
Humanities and Social Sciences
Humans
Japan
multidisciplinary
Obstetrical disseminated intravascular coagulation
Pregnancy
Pregnancy Complications, Hematologic - blood
Pregnancy Complications, Hematologic - diagnosis
Reliability
Reproducibility of Results
Science
Science (multidisciplinary)
Tentative version
Validity
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Since July 2022, obstetrical disseminated intravascular coagulation (DIC) in Japan has been diagnosed based on the new criteria (tentative version), which assesses the main underlying disease, fibrinogen level, and fibrin/fibrinogen degradation products or D-dimer level. In June 2024, the tentative version underwent minor revision and the final version was released. The previous Japanese criteria assessed underlying disease, clinical symptoms, and various laboratory findings. This study aimed to prove the effectiveness, reliability, and validity of the new criteria (final version). We analyzed 212 women with singleton pregnancies who delivered after 22 gestational weeks and experienced blood loss ≥ 1000 mL during vaginal delivery or ≥ 2000 mL during cesarean section. Those with missing laboratory findings before receiving blood transfusion at delivery were excluded. In the obstetrical DIC group, the frequency of fibrinogen levels
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-024-68298-7